Your Messages Inbox
Your Article Summary
See Latest ArticlesLilly's Zyprexa/Prozac Combo Approved for Depression
PharmExec, 03/26/09
Eli Lilly, on Monday, received approval to market its bipolar disorder treatment Symbyax—a combination of the antipsychotic Zyprexa and the antidepressant Prozac—to patients suffering from treatment-resistant depression. Symbyax becomes the first drug approved for TRD. Symbyax was approved as a bipolar treatment in 2003, and Lilly has been trying diligently to expand its indications to patients with that haven't responded to traditional drug therapies.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Article Search
Sponsor